BioSpace News Archive

Neuronetics, Inc. announced that it plans to release second quarter 2018 financial results prior to market open on Tuesday, August 14, 2018. Chris Thatcher, Chief Executive Officer, and Peter Donato, Chief Financial Officer, will host a conference call to review the Company’s results at 8:30 a.m. Eastern Time the same day.

IMV, part of the Science and Medicine Group, the leading market research and business intelligence provider to the laboratory diagnostic industry, announced the category winners of the 2018 IMV ServiceTrak™ awards in clinical analyzers.

Single Phase 3 trial may be sufficient for approval of atrial fibrillation indication

Vital Therapies, Inc. will release its second quarter 2018 financial results after the market closes on Tuesday, August 7, 2018 followed by a conference call at 4:30 p.m. ET, which will be open to the public via telephone and webcast.

Interpace Diagnostics Group, Inc. announced that it will report its second quarter 2018 financial results after the close of market on Thursday, August 9, 2018 at 4:30 p.m. ET.

Novavax, Inc. announced it will report its second quarter 2018 financial and operating results following the close of U.S. financial markets on Wednesday, August 8, 2018.

Dosed First Patient in Cohort 3 in the ADVANCE Phase 1/2 Trial of ADVM-043

At Konica Minolta Healthcare Americas, Inc., a customer-centric approach is evident by the company’s consistent top ratings from MD Buyline for its exceptional digital radiography platform and customer service.

Having met rigorous qualifications, Tempus joins a select group of commercial and academic laboratories designated to cast a wider net for patients to enter the trial

Capricor Therapeutics will report its second quarter of 2018 financial results and corporate update shortly after the NASDAQ market close on Thursday, August 9. Management will then host a webcast and conference call at 4:30 p.m. ET on August 9.